Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 3/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | APEX1 | P27695 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | GABRR1 | P24046 | 5/20 | 0.36 |
| ▸ | SLC1A2 | P43004 | 4/20 | 0.33 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.33 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.31 |
| ▸ | GABRR2 | P28476 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22361971 | 1.00 | POLB (0.48) | POLBTDP1APEX1KDM4ELMNA | |
| SCHEMBL20548051 | 1.00 | POLB (0.48) | POLBTDP1APEX1KDM4ELMNA | |
| SCHEMBL2206146 | 0.86 | KDM4E (0.39) | POLBTDP1APEX1KDM4ELMNA | |
| SCHEMBL8996504 | 0.83 | KDM4E (0.42) | POLBTDP1APEX1KDM4ELMNA | |
| SCHEMBL6811019 | 0.83 | KDM4E (0.42) | POLBTDP1APEX1KDM4ELMNA | |
| SCHEMBL24004713 | 0.82 | KDM4E (0.61) | POLBTDP1APEX1KDM4ELMNA | |
| SCHEMBL21705290 | 0.82 | KDM4E (0.61) | POLBTDP1APEX1KDM4ELMNA | |
| SCHEMBL900095 | 0.82 | KDM4E (0.61) | POLBTDP1APEX1KDM4ELMNA | |
| SCHEMBL16898630 | 0.82 | KDM4E (0.61) | POLBTDP1APEX1KDM4ELMNA | |
| SCHEMBL6161898 | 0.82 | KDM4E (0.61) | POLBTDP1APEX1KDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0790974-B1 | SUBSTITUTED 4-BIARYLBUTYRIC OR 5-BIARYLPENTANOIC ACIDS AND DERIVATIVES AS MATRIX METALLOPROTEASE INHIBITIORS | BAYER AG (US) | 2002-08-14 | — | — | EP | claimed |
| US-20010053834-A1 | Semiconductor device using polymer-containing photoresist, and process for manufacturing the same | JUNG MIN HO (KR) | 2001-12-20 | — | — | US | claimed |
| US-6132926-A | ArF photoresist copolymers | HYUNDAI ELECTRONICS INDUSTRIES CO., LTD. (KR) | 2000-10-17 | — | — | US | claimed |
| US-6045967-A | Method and device using ArF photoresist | HYUNDAI ELECTRONICS INDUSTRIES CO., LTD. (KR) | 2000-04-04 | — | — | US | claimed |
| US-6028153-A | Copolymer resin of maleimide and alicyclic olefin-based monomers, photoresist containing the copolymer resin and the preparation thereof | HYUNDAI ELECTRONICS INDUSTRIES CO., LTD. (KR) | 2000-02-22 | — | — | US | claimed |
| EP-3440051-B1 | NEUROPEPTIDE S RECEPTOR (NPSR) AGONISTS | RES TRIANGLE INST (US) | 2024-03-20 | — | — | EP | disclosed |
| CN-117417355-A | Fused heterocyclic compound, preparation method and application thereof | 上海翊石医药科技有限公司 | 2024-01-19 | — | — | CN | disclosed |
| CN-112771048-B | Inhibitors of influenza virus replication and intermediates and uses thereof | 南京药石科技股份有限公司 | 2022-08-19 | — | — | CN | disclosed |
| EP-3829719-A1 | PYRROLO[2,3-B]PYRIDIN DERIVATIVES AS INHIBITORS OF INFLUENZA VIRUS REPLICATION | Cocrystal Pharma, Inc. (US) | 2021-06-09 | — | — | EP | disclosed |
| US-10858318-B2 | Born-based cycloaddition catalysts and methods for the production of bio-based terephthalic acid, isophthalic acid and poly (ethylene terephthalate) | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2020-12-08 | — | — | US | disclosed |
| WO-2020023813-A1 | PYRROLO[2,3-B]PYRIDIN DERIVATIVES AS INHIBITORS OF INFLUENZA VIRUS REPLICATION | COCRYSTAL PHARMA, INC. (US) | 2020-01-30 | — | — | WO | disclosed |
| WO-2019060953-A1 | CHIRAL AUXILIARIES AND USES THEREOF | UNIVERSITY OF NEW ENGLAND (AU) | 2019-04-04 | — | — | WO | disclosed |
| US-6312865-B1 | Semiconductor device using polymer-containing photoresist, and process for manufacturing the same | HYUNDAI ELECTRONICS INDUSTRIES CO., LTD. (KR) | 2001-11-06 | — | — | US | disclosed |
| US-6165672-A | Maleimide or alicyclic olefin-based monomers, copolymer resin of these monomers and photoresist using the resin | HYUNDAI ELECTRONICS INDUSTRIES CO., LTD. (KR) | 2000-12-26 | — | — | US | disclosed |
| US-6166082-A | Substituted 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitors | BAYER CORPORATION (US) | 2000-12-26 | — | — | US | disclosed |
| US-6132926-A | ArF photoresist copolymers | HYUNDAI ELECTRONICS INDUSTRIES CO., LTD. (KR) | 2000-10-17 | — | — | US | disclosed |
| US-6045967-A | Method and device using ArF photoresist | HYUNDAI ELECTRONICS INDUSTRIES CO., LTD. (KR) | 2000-04-04 | — | — | US | disclosed |
| US-6028153-A | Copolymer resin of maleimide and alicyclic olefin-based monomers, photoresist containing the copolymer resin and the preparation thereof | HYUNDAI ELECTRONICS INDUSTRIES CO., LTD. (KR) | 2000-02-22 | — | — | US | disclosed |
| EP-0790974-A1 | SUBSTITUTED 4-BIARYLBUTYRIC OR 5-BIARYLPENTANOIC ACIDS AND DERIVATIVES AS MATRIX METALLOPROTEASE INHIBITIORS | Bayer Corporation (US) | 1997-08-27 | — | — | EP | disclosed |
| US-5110927-A | Hypotensive agents | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1992-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10858318-B2 | Born-based cycloaddition catalysts and methods for the production of bio-based terephthalic acid, isophthalic acid and poly (ethylene terephthalate) | ACSL4, EBPL, EML4 | POLB 714/4885TDP1 1238/4885APEX1 1048/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.